| Videos | Channels | Search |
Are high returns from marijuana companies just a pipe dream?
This week the New York Times, in an editorial, urged US lawmakers to legalise marijuana. Some states already have, but federal legislation remains unchanged. It's already possible to trade shares in marijuana companies, mostly OTC stocks, and therefore they carry plenty of risk, but could this ever grow to be an industry worth as much as the business of tobacco or alcohol. Alan Brochstein, a marijuana related investment expert and founder of 420investor.com, describes the current investment landscape for anyone thinking they can get in early by investing in what you could call, pun intended, a 'budding industry'.
05:18 minutes
Tags: alcohol, dope, drugs, drugs sector, federal law, government, governor, illegal, investing, investment, investment strategy, investments, investors, lawmakers, laws, legal, legalisation, long, long positions, long term investment, marijuana, marijuana commerce, marijuana companies, marijuana investment, marijuana investors, medical stocks, medicines, medium term trade, otc, otc stocks, penny stocks, pharma, pharma space, pharmaceutical, pharmaceutical sales, pharmaceuticals, pot, risk, risk appetite, risk assets, risk on, risk reward, risk taking, riskappetite, risks, risks in trading, sales, state law, tax, tax cut, tax cuts, tax hikes, tax policy, tax proposals, taxation, taxes, tobacco, us, us economy, usd